Plain-English translation of NCT03872661 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 2 โ Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new approach to treating stage III non-small cell lung cancer โ a type of lung cancer that cannot be surgically removed at diagnosis. The study combines four medications (including one called , a type of immunotherapy drug) given intravenously over several months, followed by surgery to remove the tumor. The goal is to shrink the cancer enough so that surgery becomes possible and improves the chance of cure.
Standard treatment for this type of advanced lung cancer using chemotherapy and radiation has limited success rates. This trial is exploring whether adding immunotherapy to chemotherapy before surgery might help more patients survive longer and be cured of their cancer.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You would receive four cycles of intravenous infusions over about three months, with each cycle lasting 21 days. During this time, you will receive four different medications on the same day each cycle. After completing all four cycles, you will wait at least three weeks, then undergo surgery to remove the lung cancer. Throughout the trial, you will have regular blood tests and imaging scans to monitor how well the treatment is working and watch for side effects.
AI-generated summary from trial data ยท Jun 30, 2026 ยท Not medical advice
China